IP Library Granted Patent US 7,666,435
Granted Patent B2
US 7,666,435 · App. 11/852,414 · Granted Feb 23, 2010

Treatment of fine wrinkles with clostridia neurotoxins

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,666,435
App. No.
11/852,414
Granted
Feb 23, 2010
Kind
B2
Abstract

Methods of using clostridial toxins and other biological agents to thin skin and control fine wrinkles in humans are provided. In preferred embodiments the methods provide beneficial effects in humans.

Claims (19)

1. A method of smoothing fine wrinkles in the skin and thinning the skin of a subject in need of such treatment which comprises administering to the dermis of said patient a therapeutically effective amount of Botulinum toxin, whereby said fine wrinkles are smoothed.

2. The method of claim 1 wherein the administration is topical.

3. The method of claim 2 wherein the Botulinum toxin is Botulinum toxin A.

4. The method of claim 1 wherein the administration is by intradermal injection.

5. The method of claim 4 comprising injection at multiple sites in the skin, wherein the sites of adjacent injections are separated by about 0.5 to 10 cm.

6. The method of claim 5 wherein the sites of adjacent injections are separated by about 1.5 to about 3 cm.

7. The method of claim 4 wherein the amount injected is between 1 and 100 U of Botulinum toxin.

8. The method of claim 7 wherein the amount injected is between 1 and 10 U of Botulinum toxin.

9. The method of claim 8 wherein the amount injected is between 2 and 3 U of Botulinum toxin.

10. The method of claim 4 wherein the Botulinum toxin is Botulinum toxin A.

11. The method of claim 1 , wherein said method is repeated periodically to inhibit the recurrence of undesirable levels of wrinkling.

12. The method of claim 11 wherein said method is repeated at intervals of from about 3 to about 6 months to inhibit said recurrence.

13. The method of claim 11 wherein said method is repeated at intervals of about 4 months to inhibit said recurrence.

14. The method of claim 1 , wherein the Botulinum toxin is Botulinum toxin B.

15. The method of claim 1 , wherein the Botulinum toxin is Botulinum toxin C.

16. The method of claim 1 , wherein the Botulinum toxin is Botulinum toxin D.

17. The method of claim 1 , wherein the Botulinum toxin is Botulinum toxin E.

18. The method of claim 1 , wherein the Botulinum toxin is Botulinum toxin F.

19. The method of claim 1 , wherein the Botulinum toxin is Botulinum toxin G.

Continuity (3)
Continuation In Part 1052430400
Provisional Application 6040437800 · Aug 19, 2002
Related Publication 20080112981A1 · May 15, 2008